Differential diagnosis of primary intrapulmonary thymoma: a report of two cases by unknown
Ishibashi et al. Surgical Case Reports  (2015) 1:56 
DOI 10.1186/s40792-015-0061-1CASE REPORT Open AccessDifferential diagnosis of primary
intrapulmonary thymoma: a report of two cases
Fumihiro Ishibashi*, Yasumitsu Moriya, Hajime Tamura, Yukiko Matsui and Toshihiko IizasaAbstract
Primary intrapulmonary thymomas (PITs), which are intrapulmonary tumors without an associated mediastinal
component, are very rare. The diagnosis of a PIT can be difficult. Here, we report two cases of resected PITs that were
difficult to differentiate from other lung tumors. The patients, of a 62-year-old man and a 64-year-old woman, had no
significant symptoms and were both referred to our hospital due to the presence of an abnormal shadow on chest
computed tomography (CT). The patients underwent 18F-fluorodeoxyglucose positron emission tomography-CT
(FDG-PET/CT) and subsequently tumor excision. A PIT was confirmed histopathologically in the surgical specimens
from both patients. In one case, the tumor consisted of a type A thymoma without abnormal FDG uptake. In the other
case, the tumor consisted of a type B2 thymoma presenting with weak FDG uptake. This report thus documents
two cases of PITs with different histopathologic and FDG-PET/CT findings. Thoracoscopic surgery is essential in
the differential diagnosis between PITs and other lung tumors.
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Thymomas are tumors derived from thymic epithelial
cells, reported to have an incidence of 0.15 per 100,000
person-years [1]. Primary intrapulmonary thymomas
(PITs) are very uncommon and have been regarded as a
disease of unknown etiology. They are defined as tumors
below the visceral pleura or entirely circumscribed by
lung parenchyma without evidence of a thymic lesion
in the anterosuperior mediastinum, which display the
characteristic histological features of thymomas [2].
PITs are difficult to diagnose. Furthermore, to the best
of our knowledge, there are no reports on the use of
18F-fluorodeoxyglucose positron emission tomography
(FDG-PET) to evaluate patients with PIT. Herein, we
report two patients with PIT, in whom a low-grade malig-
nant pulmonary tumor or metastasis was suspected on
diagnostic imaging, but PIT was ultimately diagnosed
based on tumor specimens excised via video-assisted
thoracoscopic surgery (VATS).* Correspondence: fishibashi22@yahoo.co.jp
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Case 1
A 62-year-old man was referred to our department for
evaluation of an abnormal shadow on chest computed
tomography (CT). A solitary, very small, round opacity
in the left lung was incidentally detected on chest CT
during a routine medical examination 2 years previously.
The lesion was followed radiologically at regular inter-
vals, and the size of the nodule had increased slightly.
Chest CT revealed a 15 × 10 mm tumor in the left S10
(Fig. 1). No other intrathoracic abnormalities were found,
and there were no solid lesions in the anterior mediasti-
num. FDG-PET/CT revealed a nodular lesion without ab-
normal uptake of tracer (Fig. 2). Tumor marker levels,
including carcinoembryonic antigen (CEA), cancer antigen
(CA)19-9, squamous cell carcinoma antigen (SCC), and
progastrin-releasing peptide (Pro-GRP), were all within
normal limits. We suspected the tumor to be a carcinoid
or hamartoma, and a wedge resection of the tumor was
performed under VATS. Intraoperative examination of a
frozen specimen revealed a spindle cell tumor, but no ma-
lignant cells were detected.
Macroscopic examination found a white, well-
circumscribed nodule within the lung that did not in-
volve the visceral pleura (Fig. 3a). Histopathologicrticle distributed under the terms of the Creative Commons Attribution License
hich permits unrestricted use, distribution, and reproduction in any medium,
.
Fig. 1 Chest computed tomography (CT) of case 1 shows a nodular
shadow in the left S10
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tween the tumor and lung tissue. The tumor consisted of
a dense proliferation of spindle cells, with a few spindle
cells making up pseudoglandular structures, and a cystic
lesion. A small cluster of infiltrating lymphocytes was also
observed within the tumor (Fig. 3b). Immunohistochemi-
cal studies revealed that the tumor cells were diffusely
positive for cytokeratin AE1/AE3 and cluster of differenti-
ation (CD)99 antigen and focally positive for epithelial
membrane antigen (EMA); the lymphocytes were positive
for CD1a and terminal deoxynucleotidyl transferase (TdT)
and CD20 (Fig. 3c–e). According to the World Health
Organization (WHO) classification, these histologic
findings were consistent with type A thymoma [3].
Case 2
A 64-year-old woman was noted to have an abnormal le-
sion on chest radiography. She had undergone a totalFig. 2 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)
revealed a nodular lesion with no abnormal uptake of the tracermastectomy for cancer of the right breast 26 years previ-
ously and replacement of the ascending aorta for aortic
dissection (via median sternotomy) 3 years previously.
Chest CT revealed a 9-mm tumor in the right S1 and an
11-mm tumor in the right S3 (Fig. 4a, b). There were no
solid lesions in the anterior mediastinum. FDG-PET/CT
showed slight uptake (maximum standardized uptake
value [SUV max] 2.35 and 3.45, respectively) by the two
nodular lesions (Fig. 5a, b). Tumor marker levels were
normal, except for slightly elevated SCC. Because pul-
monary metastases from breast cancer were suspected,
we performed a wedge resection under VATS.
Macroscopic examination found well-circumscribed,
white nodules (Fig. 6a). Histopathologic evaluation of
the S1 nodule found lobulated lesions with vascular
septa. Each lobule consisted of epithelial cells palisad-
ing along the septa and centrally located small lym-
phocytes (Fig. 6b). Immunohistochemical evaluation
revealed that the epithelial cells were positive for AE1/
AE3 (Fig. 6c), and the lymphocytes were positive for CD1a
and TdT (Fig. 6d). According to the WHO classification,
these histologic findings were consistent with type B2
thymoma [3].
Discussion
Primary intrapulmonary thymomas (PITs) are uncommon
lung tumors. To the best of our knowledge, 32 cases of
PITs have been reported in the English and Japanese lit-
erature since 1951, not counting our cases [2, 4–11].
Here, we present a summary of the clinicopathologic
features of all 34 cases. The patients’ ages ranged from
14 to 79 years, and half the patients were females. The
site of occurrence was the right pulmonary lobe in 21
cases, the left lobe in 12 cases, unknown in 1 case, the
upper lobe in 22 cases, and the lower lobe in 11 cases.
Three cases, including our second case 2, were multi-
focal within the same lung. The sizes of the lesions
ranged from 9 to 128 mm in diameter. The presenting
symptoms of PITs have included chest pain, cough, and
hemoptysis, which also occur in patients with lung can-
cer, but most lesions were discovered incidentally on
radiographic examination in asymptomatic individuals.
Based on the WHO classification [3], there were 7 PIT
type A cases, 8 type AB, 6 type B1, 5 type B2, and 7 type
B3; 1 case was not classified. There were 3 patients with
PIT and myasthenia gravis, and 2 patients with PIT and
immunodeficiency, which is known as Good syndrome.
PIT appears on CT as a well-circumscribed, heteroge-
neous mass, such as seen in our patients. The differen-
tial radiologic diagnosis of PIT includes low-grade
malignant tumor, metastatic lung tumor, hamartoma,
sclerosing hemangioma, lipoma, and angiolipoma. Per-
forming a preoperative diagnosis is difficult, and most
PITs are diagnosed postoperatively [10].
Fig. 4 Chest CT of case 2 shows a nodular shadow in the right S1 (a) and in the right S3 (b)
Fig. 3 The cut surface of the resected specimen of case 1 shows a well-circumscribed and whitish nodule within the lung (a). Microscopic find-
ings of the tumor include dense proliferation of spindle cells with a minority arranged in pseudoglands and a cystic lesion. An accumulation of
lymphocytes was also observed within the tumor (H&E stain) (b). The tumor cells were diffusely positive for AE1/AE3 (c), and the lymphocytes
were focally positive staining for CD1a (d) and CD20 (e)
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Fig. 6 The cut surface of the resected specimen of case 2 shows S1 (left) and S3 (right) with well-circumscribed and whitish nodules within the
lung (a). Microscopic findings of the S1 tumor show lobulated lesions with vascular septa. Each lobule consists of epithelial cells palisading along
the septa and centrally located small lymphocytes (H&E stain) (b). The epithelial cells stain positive for AE1/AE3 (c), and the lymphocytes stain
positive staining for CD1a (d)
Fig. 5 FDG-PET showed abnormal accumulation in the right S1 tumor (SUV max 2.35) (a) and in the right S3 tumor (SUV max 3.45) (b)
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was composed of dense proliferation of spindle cells with
a minority arranged in pseudoglands and a cystic lesion in
case 1, and there were lobulated lesions with vascular
septa, consisted of epithelial cells palisading along the
septa and centrally located small lymphocytes in case 2.
The differential diagnosis of PIT includes a wide range
lymphoma and primary or metastatic carcinoma of the
lung. Immunohistochemical staining is helpful in this dif-
ferentiation. Epithelial cells are stained by AE1/AE3 or
EMA, and lymphocytes in thymomas are stained by T cell
phenotypes [12]. Epithelial cell-dominant thymoma shares
the same immunoreactivity for AE1/AE3 or EMA as
metastatic carcinoma or poorly differentiated carcinomas
of the lung, but PIT appeared as well-circumscribed
lesions, with low mitotic activity and minimal atypia. The
antigen CD20 is also helpful for diagnosis of type A thym-
oma because CD20-positive B cells are found if focal
micronodular areas with a lymphoid stroma is present [3].
In our case, these tumors were diagnosed type A thymoma
and type B2 thymoma in the WHO classification, respect-
ively. Immunohistochemical staining combined with gross
and microscopic pattern of the tumor and patient’s clinical
history is helpful in differentiating a PIT from any other
intrathoracic neoplasm [10].
FDG-PET can be applied to the diagnosis of malig-
nant neoplasms because it is designed to detect and
assess the degree of carbohydrate metabolism in malig-
nant tissue [13]. The PITs of our two patients had dif-
ferent histopathologic manifestations and FDG-PET
findings. The SUVmax values of the lesions of case 2
were markedly higher than the value of the lesion of
case 1. It has been reported that FDG accumulation
was highly correlated with WHO histologic subtypes
of thymic epithelial tumors [14, 15]. Notably, the de-
gree of FDG uptake has been positively correlated with
the grade of malignancy of PITs as with the case of
thymic epithelial tumors.
Most case reports of PIT have described the tumors as
slow-growing, indolent, and asymptomatic until large
enough to cause localized effects such as pain and bron-
chial obstruction [2]. The best therapy for PIT is
complete resection, which for these tumors leads to
good outcomes [6, 8, 10]. In their systematic review of
25 cases of PIT, Myers et al. [2] reported that the sur-
vival of surgically managed patients was significantly
better than the survival of conservatively managed pa-
tients (log-rank test, P = 0.039). Histologic subtype
(WHO classification) and tumor size did not signifi-
cantly affect survival. Myasthenia gravis and the Good
syndrome significantly decreased survival (log-rank test,
P = 0.039). Because complete surgical resection was ob-
tained for both of our cases, we believe that their post-
operative outlook is good.Conclusions
PITs are very rare lesions that are difficult to diagnose.
This report described two cases of PITs, which mani-
fested different histopathologic and FDG-PET findings.
If complete surgical resection of the tumor is possible,
the postsurgical outlook is good.
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